SCHEMBL16093587

SCHEMBL16093587

CCOC(=O)c1cn(CC)nn1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.67
LMNA P02545 1/20 0.67
SMN1; SMN2 Q16637 2/20 0.60
HPGD P15428 1/20 0.60
GLA P06280 1/20 0.59
MAPK1 P28482 2/20 0.58
MEN1 O00255 1/20 0.54
TSHR P16473 1/20 0.54
KMT2A Q03164 1/20 0.54
TP53 P04637 1/20 0.52
POLB P06746 1/20 0.52
CYP1A2 P05177 1/20 0.47
SPR P35270 1/20 0.43
GAA P10253 1/20 0.43
CA1 P00915 2/20 0.43
CA2 P00918 2/20 0.43
CA9 Q16790 2/20 0.43
CA12 O43570 1/20 0.43
CA4 P22748 1/20 0.43
CA7 P43166 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12223728 0.87 ALDH1A1 (0.63) ALDH1A1LMNASMN1; SMN2HPGDGLA
SCHEMBL9502860 0.85 ALDH1A1 (0.62) ALDH1A1LMNASMN1; SMN2HPGDGLA
SCHEMBL3677898 0.85 ALDH1A1 (0.62) ALDH1A1LMNASMN1; SMN2HPGDGLA
SCHEMBL7424494 0.84 ALDH1A1 (0.49) ALDH1A1LMNASMN1; SMN2HPGDGLA
SCHEMBL23382244 0.84 ALDH1A1 (0.60) ALDH1A1LMNASMN1; SMN2HPGDGLA
SCHEMBL12197486 0.84 ALDH1A1 (0.60) ALDH1A1LMNASMN1; SMN2HPGDGLA
SCHEMBL18579724 0.84 ALDH1A1 (0.60) ALDH1A1LMNASMN1; SMN2HPGDGLA
SCHEMBL15931713 0.84 ALDH1A1 (0.60) ALDH1A1LMNASMN1; SMN2HPGDGLA
SCHEMBL18589075 0.83 ALDH1A1 (0.59) ALDH1A1LMNASMN1; SMN2HPGDGLA
SCHEMBL30322942 0.83 ALDH1A1 (0.59) ALDH1A1LMNASMN1; SMN2HPGDGLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2999707-B1 TYLOSIN DERIVATIVES AND METHOD FOR PREPARATION THEREOF BAYER ANIMAL HEALTH GMBH (DE) 2018-03-28 EP disclosed
EP-2782922-B1 ANTIBACTERIAL TYLOSIN DERIVATIVES AND METHODS FOR THEIR PREPARATION BAYER IP GMBH (DE) 2017-12-20 EP disclosed
US-9771389-B2 Tylosin derivatives and method for preparation thereof THE KITASAKO INSTITUTE (JP) 2017-09-26 US disclosed
US-9593140-B2 Antibacterial tylosin derivatives and methods for their preparation BAYER INTELLECTUAL PROPERTY GMBH (DE) 2017-03-14 US disclosed
US-20160108077-A1 TYLOSIN DERIVATIVES AND METHOD FOR PREPARATION THEREOF THE KITASAKO INSTITUTE (JP) 2016-04-21 US disclosed
US-20140349954-A1 ANTIBACTERIAL TYLOSIN DERIVATIVES AND METHODS FOR THEIR PREPARATION ELANCO ANIMAL HEALTH GMBH (DE) 2014-11-27 US disclosed
US-8841306-B2 Antimicrobials PANACEA BIOTEC LTD. (IN) 2014-09-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160108077-A1 TYLOSIN DERIVATIVES AND METHOD FOR PREPARATION THEREOF TMSB10, MLN, TMSB4X ALDH1A1 4662/4885LMNA 565/4885SMN1; SMN2 1979/4885
US-20140349954-A1 ANTIBACTERIAL TYLOSIN DERIVATIVES AND METHODS FOR THEIR PREPARATION MLN, TMSB10, TMSB4X ALDH1A1 4561/4885LMNA 1069/4885SMN1; SMN2 1931/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.